New Imaging Technique Developed To Test The Physical Properties Of Tumors

A drug’s efficacy on a tumor can be checked physically by a new imaging technique. This technique is capable of detecting if the inner core of the tumor is getting affected by the anti-cancer drug or not.

A new imaging technique can tell us what goes on inside the tumor internally once an anticancer drug is given. A drug’s effectiveness on the physical aspect of the tumor can get tested here. The results of this study are published in the journal of //Physical Review Letters.

A team of physicists at the Institut Lumière Matière (CNRS/Université Claude Bernard Lyon 1), in collaboration with the Cancer Research Center of Lyon (CNRS/INSERM/ Université Claude Bernard Lyon 1//Centre Léon Bérard/Hospices civils de Lyon), has demonstrated the potential, for oncology, of an imaging technique based only on the physical properties of tumors.

Solid Stress from Brain Tumors Causes Neurologic Dysfunction
Solid stress identified as a new biomechanical abnormality in tumors, but little has been known about how these forces affect tissues surrounding a brain tumor, potentially impairing neurological function.

It can differentiate populations of malignant cells and monitor how effective an anticancer treatment is. These results, published in Physical Review Letters on January 8, 2019, should help in the design of new therapeutic molecules and in the personalization of treatments.

Despite a good understanding of the biology of cancer, 90% of experimental drugs fail during clinical trials. It is also increasingly suspected that the mechanical properties of tumors influence disease progression, and treatment efficacy.

Although we can evaluate tumor elasticity globally, it is more difficult to measure local rigidity deep down and to see whether the core of the tumor resists the penetration of therapeutic liquids.

Tumors Backfire on Chemotherapy, Reveals Study
Researchers identified increased levels of annexin-A6 also in the exosomes of breast cancer patients undergoing neoadjuvant chemotherapy.

To probe these physical properties, the researchers have used a non-contact imaging technique that does not require the use of contrast agents - therefore that does not disturb tissue function - that exploits infinitesimal natural vibrations of matter.

To recapitulate the behavior of colorectal tumors in vitro, the researchers created organoids, spheres with diameter 0.3 mm formed by the aggregation of tumor cells. They focused a red laser beam onto these objects. The infinitesimal vibrations of the sample, generated by thermal agitation, modify very slightly the color of the light beam that exits the sample. By analyzing this light, a map of the mechanical properties of the model tumors is created: the more rigid the area scanned by the laser, the faster the vibrations and, in a manner comparable to the Doppler effect (the mechanism that makes a siren sound increasingly shrill as it gets closer), the greater the color change.

New Way to Cut Blood Supply of Tumors
Vascularization of tumors can be controlled through a gene which is overexpressed in tumor blood vessels, thereby cutting the power of tumors

From organoids composed of two cell lines with different malignancies, the researchers have shown that they could distinguish the two cell types from their mechanical properties. Such information is crucial because it may allow diagnosis from biopsy analysis to be refined and offer a better assessment of tumor grade.

Local variations in mechanical properties after a drug treatment have also been monitored using this technique: the center of the tumor remains rigid longer than the edge, demonstrating the treatment's efficacy gradient. So the local measurement of mechanical properties could confirm the total destruction of the tumor and help in choosing as low a treatment dose and duration as possible.

Elevated Risk of Rare Blood Cancers After Chemotherapy for Most Solid Tumors Identified
Scientists aimed to quantify the risk of developing tMDS/AML, a rare but often fatal blood cancer, in patients treated with chemotherapy.

This approach allows exploring the impact of mechanical properties on the therapeutic response. It should lead to more predictive in vitro tumor models for testing new therapeutic molecules and for combined therapies, which act for example on tissue rigidity to accelerate the penetration of active molecules in the center of the tumor. It could also provide new indicators to guide clinicians in the personalization of therapies.

Source-Eurekalert